---
figid: PMC7766850__ijms-21-09633-g008
figlink: pmc/articles/PMC7766850/figure/ijms-21-09633-f008/
number: F8
caption: Scheme of the effects of AMPAR antagonists on spontaneous seizure activity
  in epilepsy rats based on a previous [] and the present studies. In epilepsy rats,
  GluN2B Y1472 and CREB phosphorylations may be increased by multiple signaling pathways,
  such as protein kinase A (PKA), protein kinase C (PKC), and cyclin-dependent kinase
  5 (CDK5). In addition, Src-CK2 axis may be inhibited as a compensatory response
  to the decreased PTEN expression via unknown mechanisms. However, this adaptive
  response may be insufficient to abrogate the hyper-phosphorylations of GluN2B and
  CREB. In responders, perampanel and GYKI 52,466 may further decrease Src-CK2 activity,
  which leads to increased PTEN activity (dephosphorylation) concomitant with its
  upregulation. Subsequently, the elevated PTEN activity may dephosphorylate GluN2B
  Y1472 and CREB S133 site that facilitate GRIA1 surface expression, concomitant with
  downregulation of phosphoinositide 3-kinase (PI3K)/AKT1 signaling pathway. These
  phenomena are not observed in non-responders and the dipotassium bisperoxovanadium(pic)
  dihydrate (BpV(pic), a PTEN inhibitor)-treated animals. Therefore, the present study
  demonstrates that this Src/CK2/PTEN-mediated GluN2B and CREB regulation may be required
  for the anti-epileptic effects of AMPAR antagonists.
pmcid: PMC7766850
papertitle: Src/CK2/PTEN-Mediated GluN2B and CREB Dephosphorylations Regulate the
  Responsiveness to AMPA Receptor Antagonists in Chronic Epilepsy Rats.
reftext: Ji-Eun Kim, et al. Int J Mol Sci. 2020 Dec;21(24):9633.
pmc_ranked_result_index: '33081'
pathway_score: 0.9165223
filename: ijms-21-09633-g008.jpg
figtitle: Scheme of the effects of AMPAR antagonists on spontaneous seizure activity
  in epilepsy rats based on a previous  and the present studies
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7766850__ijms-21-09633-g008.html
  '@type': Dataset
  description: Scheme of the effects of AMPAR antagonists on spontaneous seizure activity
    in epilepsy rats based on a previous [] and the present studies. In epilepsy rats,
    GluN2B Y1472 and CREB phosphorylations may be increased by multiple signaling
    pathways, such as protein kinase A (PKA), protein kinase C (PKC), and cyclin-dependent
    kinase 5 (CDK5). In addition, Src-CK2 axis may be inhibited as a compensatory
    response to the decreased PTEN expression via unknown mechanisms. However, this
    adaptive response may be insufficient to abrogate the hyper-phosphorylations of
    GluN2B and CREB. In responders, perampanel and GYKI 52,466 may further decrease
    Src-CK2 activity, which leads to increased PTEN activity (dephosphorylation) concomitant
    with its upregulation. Subsequently, the elevated PTEN activity may dephosphorylate
    GluN2B Y1472 and CREB S133 site that facilitate GRIA1 surface expression, concomitant
    with downregulation of phosphoinositide 3-kinase (PI3K)/AKT1 signaling pathway.
    These phenomena are not observed in non-responders and the dipotassium bisperoxovanadium(pic)
    dihydrate (BpV(pic), a PTEN inhibitor)-treated animals. Therefore, the present
    study demonstrates that this Src/CK2/PTEN-mediated GluN2B and CREB regulation
    may be required for the anti-epileptic effects of AMPAR antagonists.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SRC
  - PRKACG
  - PRKAR1A
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKAR1B
  - PRKCA
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCQ
  - PRKCB
  - PRKCD
  - PRKCI
  - PRKCZ
  - PRKD3
  - CSNK2A1
  - CSNK2A2
  - CSNK2B
  - ATF2
  - CREB5
  - CREB3
  - CREB3L3
  - ATF1
  - CREB1
  - CREM
  - CREB3L2
  - CREB3L1
  - CREB3L4
  - PTEN
  - GRIA1
  - GRIA3
  - GRIA4
  - GRIA2
  - GRIN2B
  - CDK5
  - pilocarpine
  - GYKI 52466
  - Seizures
genes:
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: PKC(?)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC(?)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC(?)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC(?)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC(?)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC(?)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC(?)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC(?)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC(?)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKC(?)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: CK2
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2A1
  entrez: '1457'
- word: CK2
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2A2
  entrez: '1459'
- word: CK2
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2B
  entrez: '1460'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: GRIA
  symbol: GRIA
  source: bioentities_symbol
  hgnc_symbol: GRIA1
  entrez: '2890'
- word: GRIA
  symbol: GRIA
  source: bioentities_symbol
  hgnc_symbol: GRIA3
  entrez: '2892'
- word: GRIA
  symbol: GRIA
  source: bioentities_symbol
  hgnc_symbol: GRIA4
  entrez: '2893'
- word: GRIA
  symbol: GRIA
  source: bioentities_symbol
  hgnc_symbol: GRIA2
  entrez: '2891'
- word: GluN2B
  symbol: GluN2B
  source: hgnc_alias_symbol
  hgnc_symbol: GRIN2B
  entrez: '2904'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: CDK5(?)
  symbol: CDK5
  source: hgnc_symbol
  hgnc_symbol: CDK5
  entrez: '1020'
- word: CDK5
  symbol: CDK5
  source: hgnc_symbol
  hgnc_symbol: CDK5
  entrez: '1020'
chemicals:
- word: pilocarpine
  source: MESH
  identifier: D010862
- word: GYKI 52466
  source: MESH
  identifier: C061950
diseases:
- word: Seizures
  source: MESH
  identifier: D012640
figid_alias: PMC7766850__F8
redirect_from: /figures/PMC7766850__F8
figtype: Figure
---
